1-6 of 6
Sumit Isharwal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-017: Minnelide reduces castration-resistant and enzalutamide-resistant prostate cancer via downregulation of androgen receptor-mediated signaling

Sumit Isharwal, Shrey Modi, Usman Barlass, Vikas Dudeja, Ashok Saluja, Sulagna Banerjee, Badrinath Konety
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): LB-017.
https://doi.org/10.1158/1538-7445.AM2015-LB-017
Published: 01 August 2015
View article titled, Abstract LB-017: Minnelide reduces castration-resistant and enzalutamide-resistant prostate cancer via downregulation of androgen receptor-mediated signaling
Journal Articles

Abstract 2236: Nuclear roundness variance predicts prostate cancer progression, metastasis and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy

Robert W. Veltri, Sumit Isharwal, Craig Miller, Jonathan I. Epstein, Alan W. Partin
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2236.
https://doi.org/10.1158/1538-7445.AM10-2236
Published: 15 April 2010
View article titled, Abstract 2236: Nuclear roundness variance predicts prostate cancer progression, metastasis and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy
Journal Articles

Abstract 2731: Serum prostate health index and biopsy tissue DNA content at the time of diagnosis predicts the need for treatment in men enrolled in an active surveillance program

Sumit Isharwal, Danil Makarov, Lori J. Sokoll, Patricia Landis, Cameron Marlow, Jonathan I. Epstein, Alan W. Partin, H. Ballentine Carter, Robert W. Veltri
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2731.
https://doi.org/10.1158/1538-7445.AM10-2731
Published: 15 April 2010
View article titled, Abstract 2731: Serum prostate health index and biopsy tissue DNA content at the time of diagnosis predicts the need for treatment in men enrolled in an active surveillance program
Journal Articles

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

Rong Hu, Thomas A. Dunn, Shuanzeng Wei, Sumit Isharwal, Robert W. Veltri, Elizabeth Humphreys, Misop Han, Alan W. Partin, Robert L. Vessella, William B. Isaacs, G. Steven Bova, Jun Luo
Journal: Cancer Research
Cancer Res (2009) 69 (1): 16–22.
https://doi.org/10.1158/0008-5472.CAN-08-2764
Published: 31 December 2008
View article titled, Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Open the PDF for Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo

Madeleine Kortenhorst, Sumit Isharwal, Paul van Diest, Wasim Chowdhury, Cameron Marlow, Michael Carducci, Ronald Rodriguez, Robert Veltri
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2615.
Published: 01 May 2008
View article titled, Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells<em> in vitro</em> and<em> in vivo</em>
Journal Articles

A novel membrane p17 protein biomarker is overexpressed in metastatic human and rat (Dunning) prostate cancer cell lines, human prostate tissues and serum.

Rojahn Elizabeth, Sumit Isharwal, Gunjan Malik, Alan Partin, Robert Veltri
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5435.
Published: 01 May 2007
View article titled, A novel membrane p17 protein biomarker is overexpressed in metastatic human and rat (Dunning) prostate cancer cell lines, human prostate tissues and serum.